Atlas Trials

Intravitreal Ranibizumab Injection for Aggressive Versus Type 1 Prethreshold Retinopathy of Prematurity

Clinical trial NCT05701124 · COMPLETED

Trial details

NCT number
NCT05701124
Sponsor
Zagazig University
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Retina DiseaseRetinopathy of PrematurityRanibizumab
Start date
2020-11-20
Primary completion
2022-11-20
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.